An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s.Scientists have created a drug that ...

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.

The research, published in Alzheimer's & Dementia ... we have a drug which is effective in inhibiting both these regions. This dual-targeting mechanism is significant because it addresses both ...

"For the first time, we have a drug which is effective in inhibiting both these regions. "This dual-targeting mechanism is significant ... test that could predict dementia up to nine years ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Researchers say a new drug could stop Alzheimer's in its tracksResearchers have hailed a promising breakthrough in the ...